ROBERT NELSEN - 12 Aug 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director, 10%+ Owner
Signature
By: Robert Nelsen, Managing Director, By: /s/ Mark McDonnell, as Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
12 Aug 2022
Net transactions value
$0
Form type
4
Filing time
16 Aug 2022, 21:05:42 UTC
Previous filing
07 Jul 2022
Next filing
22 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -217,781 -2.8% $0.000000 7,586,037 12 Aug 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282,219 -2.8% $0.000000 9,830,626 12 Aug 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +27,489 +9.3% $0.000000 322,723 12 Aug 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1,684 +9.9% $0.000000 18,747 12 Aug 2022 See footnote F1, F4, F5
transaction VIR Common Stock Other $0 -217,781 -2.9% $0.000000 7,368,256 15 Aug 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282,219 -2.9% $0.000000 9,548,407 15 Aug 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +27,489 +8.5% $0.000000 350,212 15 Aug 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1,684 +9% $0.000000 20,431 15 Aug 2022 See footnote F1, F4, F5
transaction VIR Common Stock Other $0 -217,781 -3% $0.000000 7,150,475 16 Aug 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 -282,219 -3% $0.000000 9,266,188 16 Aug 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 +27,489 +7.8% $0.000000 377,701 16 Aug 2022 Direct F1, F4, F5
transaction VIR Common Stock Other $0 +1,684 +8.2% $0.000000 22,115 16 Aug 2022 See footnote F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Distribution of Common Stock held by a limited partnership to its partners for no consideration.
F2 The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
F3 The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
F4 Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
F5 Shares held by a trust for the benefit of family members of the Reporting Person.